Regenerative medicine in andrology: Tissue engineering and gene therapy as potential treatment options for penile deformations and erectile dysfunction

European Urology

Volumn 46, Issue 2, 2004, Pages 162-169

  Schultheiss, Dirk ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Andrology; Erectile dysfunction; Gene therapy; Penile deformation; Tissue engineering

Indexed keywords

ADENOVIRUS VECTOR; ANDROGEN; ANTISENSE OLIGONUCLEOTIDE; CALCITONIN GENE RELATED PEPTIDE; GROWTH FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NITRIC OXIDE SYNTHASE; PLASMID DNA; POTASSIUM; POTASSIUM CHANNEL; PROTEIN INHIBITOR; RETROVIRUS VECTOR; RHO KINASE; SILICONE; SOMATOMEDIN; SUPEROXIDE DISMUTASE; VASCULOTROPIN; VIRUS VECTOR;

ANDROGEN THERAPY; ANDROLOGY; AUTOTRANSPLANTATION; CARTILAGE; CARTILAGE CELL; CORPUS CAVERNOSUM; ENDOTHELIUM CELL; ERECTILE DYSFUNCTION; GENE GUN; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETIC ENGINEERING; GLIA CELL; HUMAN; MEDICINE; METHODOLOGY; MUTAGENESIS; NERVE; NERVE RECONSTRUCTION; NERVE REGENERATION; NONHUMAN; PENIS DISEASE; PENIS ERECTION; PEYRONIE DISEASE; PLASTIC SURGERY; PRIORITY JOURNAL; REVIEW; SILICONE PROSTHESIS; SMOOTH MUSCLE RELAXATION; TISSUE ENGINEERING; TREATMENT INDICATION; TUNICA ALBUGINEA;

ANDROLOGY; ANIMALS; GENE THERAPY; HUMANS; IMPOTENCE; MALE; PENIS; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

EID: 3142574863     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2004.02.001     Document Type: Review

References (68)

1. Atala A. Regenerative medicine and urology. BJU Int. 92(Suppl 1):2003;58-67
2. Cross W.R., Thomas D.F., Southgate J. Tissue engineering and stem cell research in urology. BJU Int. 92:2003;165-171
3. Ninkovic M., Dabernig W. Flap technology for reconstructions of urogenital organs. Curr. Opin. Urol. 13:2003;483-488
4. Sievert K.D. Vaginal and penile reconstruction. Curr. Opin. Urol. 13:2003;489-494
5. Atala A. Experimental and clinical experience with tissue engineering techniques for urethral reconstruction. Urol Clin North Am 2002;29:485-92, ix.
6. Bannasch H., Fohn M., Unterberg T., Bach A.D., Weyand B., Stark G.B. Skin tissue engineering. Clin. Plast. Surg. 30:2003;573-579
7. Kershen R.T., Yoo J.J., Moreland R.B., Krane R.J., Atala A. Reconstitution of human corpus cavernosum smooth muscle in vitro and in vivo. Tissue Eng. 8:2002;515-524
8. Park H.J., Yoo J.J., Kershen R.T., Moreland R., Atala A. Reconstitution of human corporal smooth muscle and endothelial cells in vivo. J. Urol. 162:1999;1106-1109
9. Falke G., Yoo J.J., Kwon T.G., Moreland R., Atala A. Formation of corporal tissue architecture in vivo using human cavernosal muscle and endothelial cells seeded on collagen matrices. Tissue Eng. 9:2003;871-879
10. Kwon T.G., Yoo J.J., Atala A. Autologous penile corpora cavernosa replacement using tissue engineering techniques. J. Urol. 168:2002;1754-1758
11. Biers S.M., Brading A.F. Nerve regeneration: might this be the only solution for functional problems of the urinary tract? Curr. Opin. Urol. 13:2003;495-500
12. Nomi M., Atala A., Coppi P.D., Soker S. Principals of neovascularization for tissue engineering. Mol. Aspects Med. 23:2002;463-483
13. Wessells H., Williams S.K. Endothelial cell transplantation into the corpus cavernosum: moving towards cell-based gene therapy. J. Urol. 162:1999;2162-2164
14. Chancellor M.B., Tirney S., Mattes C.E., Tzeng E., Birder L.A., Kanai A.J., et al. Nitric oxide synthase gene transfer for erectile dysfunction in a rat model. BJU Int. 91:2003;691-696
15. Deng W., Bivalacqua T.J., Chattergoon N.N., Hyman A.L., Jeter J.R. Jr., Kadowitz P.J. Adenoviral gene transfer of eNOS: high-level expression in ex vivo expanded marrow stromal cells. Am. J. Physiol. Cell Physiol. 285:2003;C1322-C1329
16. Tirney S., Mattes C.E., Yoshimura N., Yokayama T., Ozawa H., Tzeng E., et al. Nitric oxide synthase gene therapy for erectile dysfunction: comparison of plasmid, adenovirus, and adenovirus-transduced myoblast vectors. Mol. Urol. 5:2001;37-43
17. Yoo JJ, Lee I, Atala A. Cartilage rods as a potential material for penile reconstruction. J Urol 1998;160:1164-8 [Discussion 1178].
18. Yoo J.J., Park H.J., Lee I., Atala A. Autologous engineered cartilage rods for penile reconstruction. J. Urol. 162:1999;1119-1121
19. Kim B.S., Yoo J.J., Atala A. Engineering of human cartilage rods: potential application for penile prostheses. J. Urol. 168:2002;1794-1797
20. Bogoraz N.A. On complete plastic reconstruction of a penis sufficient for coitus [in Russian]. Soviet Surgery [Sovetskaya khirurgiya]. 8:1936;303-309
21. Bogoraz NA. Reconstructive Surgery [in Russian]. Vol. 2. Moscow: Medgis; 1948.
22. Perovic S.V., Djordjevic M.L. Penile lengthening. BJU Int. 86:2000;1028-1033
23. Carson C.C., Chun J.L. Peyronie's disease: surgical management: autologous materials. Int. J. Impot. Res. 14:2002;329-335
24. Lahme S., Gotz T., Bichler K.H. Collagen fleece for defect coverage following plaque excision in patients with Peyronie's disease. Eur. Urol. 41:2002;401-405
25. Wefer J., Schlote N., Sekido N., Sievert K.D., Wefer A.E., Nunes L., et al. Tunica albuginea acellular matrix graft for penile reconstruction in the rabbit: a model for treating Peyronie's disease. BJU Int. 90:2002;326-331
26. Soergel TM, Cain MP, Kaefer M, Gitlin J, Casale AJ, Davis MM, et al. Complications of small intestinal submucosa for corporal body grafting for proximal hypospadias. J Urol 2003;170:1577-8; 1578-9.
27. Schultheiss D, Lorenz RR, Gabouev AI, Schlote N, Wefer J, Mertsching H, et al. Functional tissue engineering of autologous tunica albuginea: a possible graft for Peyronie's disease surgery. Eur Urol Suppl 2003;2(1):123 [Abstract 483].
28. Meuleman EJ, Mulders PF. Erectile function after radical prostatectomy: a review. Eur Urol 2003;43:95-101 [Editorial Comment by F. Montorsi 101-2].
29. Burnett AL. Neuroprotection and nerve grafts in the treatment of neurogenic erectile dysfunction. J Urol 2003;170:S31-4 [Discussion S34].
30. Quinlan D.M., Nelson R.J., Walsh P.C. Cavernous nerve grafts restore erectile function in denervated rats. J. Urol. 145:1991;380-383
31. Walsh P.C. Nerve grafts are rarely necessary and are unlikely to improve sexual function in men undergoing anatomic radical prostatectomy. Urology. 57:2001;1020-1024
32. May F, Weidner N, Mrva T, Caspers C, Gänsbacher B, Hartung R. Schwann cell grafts are superior to autologous nerve grafts for repair of ablated cavernosal nerves in rats. Eur Urol Suppl 2003;2(1):72 [Abstract 278].
33. May F., Weidner N., Caspers C., Mrva T., Matiasek K., Gänsbacher B., et al. GDNF-hypersecreting Schwann cells enhance regeneration of erectile nerves in rats. Urologe A. 42:2003;S26
34. Hsieh P.S., Bochinski D.J., Lin G.T., Nunes L., Lin C.S., Lue T.F. The effect of vascular endothelial growth factor and brain-derived neurotrophic factor on cavernosal nerve regeneration in a nerve-crush rat model. BJU Int. 92:2003;470-475
35. Bakircioglu M.E., Lin C.S., Fan P., Sievert K.D., Kan Y.W., Lue T.F. The effect of adeno-associated virus mediated brain derived neurotrophic factor in an animal model of neurogenic impotence. J. Urol. 165:2001;2103-2109
36. Gholami S.S., Rogers R., Chang J., Ho H.C., Grazziottin T., Lin C.S., et al. The effect of vascular endothelial growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia. J. Urol. 169:2003;1577-1581
37. Kim J.H., Bennett N.E., Sasaki K., Yoshimura N., Wolfe D.P., Goins W.F., et al. Neurotrophic factor gene therapy: potential cure for post radical prostatectomy erectile dysfunction. J. Urol. 169(Suppl):2003;303-304
38. Bivalacqua T.J., Hellstrom W.J. Potential application of gene therapy for the treatment of erectile dysfunction. J. Androl. 22:2001;183-190
39. Christ G.J. Frontiers in gene therapy for erectile dysfunction. Int. J. Impot. Res. 15(Suppl 5):2003;S33-S40
40. Tyagi P., Chancellor M.B., Yoshimura N., Kim J.H., Bennett N.E., Huang L. Proof of concept of using the bio-bolistic gene transfer (gene gun) to the rat penis. J. Urol. 169(Suppl):2003;307
41. Christ G.J., Melman A. The application of gene therapy to the treatment of erectile dysfunction. Int. J. Impot. Res. 10:1998;111-112
42. Garban H., Marquez D., Magee T., Moody J., Rajavashisth T., Rodriguez J.A., et al. Cloning of rat and human inducible penile nitric oxide synthase. Application for gene therapy of erectile dysfunction. Biol. Reprod. 56:1997;954-963
43. Rehman J., Christ G., Melman A., Werber J., Alyskewycz M., Staerman F., et al. Enhancement of physiologic erectile dysfunction with nitric oxide synthase gene therapy. J. Urol. 157(Suppl):1997;201
44. Magee T.R., Ferrini M., Garban H.J., Vernet D., Mitani K., Rajfer J., et al. Gene therapy of erectile dysfunction in the rat with penile neuronal nitric oxide synthase. Biol. Reprod. 67:2002;1033-1041
45. Magee T., Davila H.H., Ferrini M.G., Raijfer J., Gonzalez-Cadavid N.F. Gene transfer of antisense PIN (protein inhibitor of NOS cDNA) ameliorates aging-related erectile dysfunction in the rat. J. Urol. 169(Suppl):2003;305
46. Champion H.C., Bivalacqua T.J., Hyman A.L., Ignarro L.J., Hellstrom W.J., Kadowitz P.J. Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. Proc. Natl. Acad. Sci. USA. 96:1999;11648-11652
47. Bivalacqua T.J., Champion H.C., Mehta Y.S., Abdel-Mageed A.B., Sikka S.C., Ignarro L.J., et al. Adenoviral gene transfer of endothelial nitric oxide synthase (eNOS) to the penis improves age-related erectile dysfunction in the rat. Int. J. Impot. Res. 12(Suppl 3):2000;S8-17
48. Bivalacqua T.J., Usta M.F., Champion H.C., Adams D., Namara D.B., Abdel-Mageed A.B., et al. Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats. J. Urol. 169:2003;1911-1917
49. Christ G.J. K channels as molecular targets for the treatment of erectile dysfunction. J. Androl. 23:2002;S10-S19
50. Christ G.J., Rehman J., Day N., Salkoff L., Valcic M., Melman A., et al. Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function. Am. J. Physiol. 275:1998;H600-H608
51. Melman A., Zhao W., Davies K.P., Bakal R., Christ G.J. The successful long-term treatment of age related erectile dysfunction with hSlo cDNA in rats in vivo. J. Urol. 170:2003;285-290
52. Lee S.W., Chae M.R., Kim S.H., So I. Ex vivo gene transfer of KATP channel produces physiological alterations in corporal smooth muscle cells. Int. J. Impot. Res. 15(Suppl 6):2003;S2
53. Chitaley K., Bivalacqua T.J., Champion H.C., Usta M.F., Hellstrom W.J., Mills T.M., et al. Adeno-associated viral gene transfer of dominant negative RhoA enhances erectile function in rats. Biochem. Biophys. Res. Commun. 298:2002;427-432
54. Bivalacqua T.J., Champion H.C., Abdel-Mageed A.B., Kadowitz P.J., Hellstrom W.J. Gene transfer of prepro-calcitonin gene-related peptide restores erectile function in the aged rat. Biol. Reprod. 65:2001;1371-1377
55. * and improves erectile function in aged rats. Am. J. Physiol. Heart Circ. Physiol. 284:2003;H1408-H1421
56. Rogers R.S., Graziottin T.M., Lin C.S., Kan Y.W., Lue T.F. Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int. J. Impot. Res. 15:2003;26-37
57. Burchardt M., Burchardt T., Buttyan R., Anastasiadis A., De La Taille A., Shabsigh A., et al. Angiogenic factors for therapy of ED: protein and DNA transfer of VEGF in the rat penis. J. Urol. 169(Suppl):2003;309-310
58. Park K., Ahn K., Kim K.K., Kim M.K., Ryu S.B. Effects of intracavernosal IGF-1 gene delivery on erectile function in the aging rat. Int. J. Impot. Res. 15:2003;S35
59. Kausch I., Bohle A. Antisense oligonucleotide therapy for urologic tumors. Curr. Urol. Rep. 4:2003;60-69
60. Kim R., Tanabe K., Emi M., Uchida Y., Toge T. Potential roles of antisense therapy in the molecular targeting of genes involved in cancer (review). Int. J. Oncol. 24:2004;5-17
61. Bai W.J., Hou S.K., Wang X.F., Yan Z., He P.Y., Deng Q.P., et al. The effects of antisenes oligodeoxynucleotide on the cyclic nucleotide monophosphates in smooth muscle cells of human corpus cavernosum. Zhonghua Nan Ke Xue. 8:2002;88-91
62. Jackson G., Betteridge J., Dean J., Eardley I., Hall R., Holdright D., et al. A systematic approach to erectile dysfunction in the cardiovascular patient: a Consensus Statement - update 2002. Int. J. Clin. Pract. 56:2002;663-671
63. Montorsi P., Montorsi F., Schulman C.C. Is erectile dysfunction the "tip of the iceberg" of a systemic vascular disorder? Eur. Urol. 44:2003;352-354
64. Champion H.C., Bivalacqua T.J., Greenberg S.S., Giles T.D., Hyman A.L., Kadowitz P.J. Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice. Proc. Natl. Acad. Sci. USA. 99:2002;13248-13253
65. Champion H.C., Bivalacqua T.J., Toyoda K., Heistad D.D., Hyman A.L., Kadowitz P.J. In vivo gene transfer of prepro-calcitonin gene-related peptide to the lung attenuates chronic hypoxia-induced pulmonary hypertension in the mouse. Circulation. 101:2000;923-930
66. Bivalacqua T.J., Hyman A.L., Kadowitz P.J., Paolocci N., Kass D.A., Champion H.C. Role of calcitonin gene-related peptide (CGRP) in chronic hypoxia-induced pulmonary hypertension in the mouse. Influence of gene transfer in vivo. Regul. Pept. 108:2002;129-133
67. Ghofrani H.A., Wiedemann R., Rose F., Schermuly R.T., Olschewski H., Weissmann N., et al. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet. 360:2002;895-900
68. Kleinsasser A, Loeckinger A. Sildenafil for lung fibrosis and pulmonary hypertension. Lancet 2003;361:262-3 [Author reply 263].